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Abstract
We study longevity and usage of medical resources of a sample of
individuals aged 65 years or more who are covered by a private in-
surance policy. A longitudinal analysis is presented, where the yearly
cumulative number of medical coverage requests by each subject char-
acterizes insurance intensity of care until death. We confirm that there
is a significant correlation between the longitudinal data on usage level
and the survival time processes. We obtain dynamic estimations of
event probabilities and we exploit the potential of joint models for
personalized survival curve adjustment.
1 Introduction
The gradual development of medical science and technology leads to a larger
number of years lived with disabilities, which in turn increases the demand
of medical resources. This is a key challenge for health insurance companies
∗The support received from the Spanish Ministry of Science/FEDER ECO2013-48326-
C2-1-P is acknowledged. Guille´n thanks ICREA Academia.
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who have to face additional costs in order to meet the care needs in the
event of a large cohort of elderly people. Furthermore, it is well known that
private insurance policy holders are generally supposed to have a higher socio-
economic level compared to the rest of the population because they can afford
private health coverage (Schoen et al., 2010). So, the mortality tables of the
general population may be biased for the insureds subgroup and insurance
companies estimate specific survival probabilities for their portfolios using
standard actuarial methods (Yue and Huang, 2011; Denuit, 2009; Denuit and
Frostig, 2008). In practice, however, they disregard longitudinal information
on their policy holders that is continuously being collected. Health insurance
companies accumulate data on the intensity and the type of use of medical
resources which can be extremely valuable to predict personalized survival
probabilities and to quantify the risk of medical care demand of their clients
above the expected values.
The aim of our study is to show how historical and follow-up records,
which are in fact repeated measures of a longitudinal marker that counts the
number of times that the policy holder has used the insurance policy coverage,
can effectively predict personalized survival probabilities. Our proposed joint
modeling approach, which is a powerful methodology that has recently been
introduced in statistics for medicine (Rizopoulos and Lesaffre, 2014, see),
allows to examine the association between a given medical care usage trend
and longevity prospects.
In is well known that medical usage intensity increases substantially at
older ages (Blane et al., 2008) and end-of-life care expenditures is significantly
larger than throughout life (Dao et al., 2014; Murphy, 2012), but according
to Bird et al. (2002) men’s and women’s health care experiences differ as
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they age. While increasing attention has been focused on gender differences
in health status, prevalence of illnesses, and access to quality care among
older adults, little is known about differences in their health care in the last
years of their lives. This is precisely what we study.
The dynamic personalized predictions that we are aiming at are based on
both baseline subject’s time-to-event covariates, recorded at the start of the
study, and subject’s longitudinal information measured at fixed time points
within an observation window. Therefore, both the longitudinal and the
survival information is part of a single statistical model, which allows :(i)
to establish the degree of association between the value of the longitudinal
variable and the time to event outcome, (ii) to estimate subject-specific sur-
vival probabilities based on personalized longitudinal outcomes and (iii) to
update personalized survival estimations as additional longitudinal responses
are collected. This can provide a comprehensive risk assessment of a health
insurance portfolio using all available information.
To the best of our knowledge, no study has evaluated how health care
usage and risk of death can be modeled jointly. The main results of our
analysis are: 1) we confirm age and gender are main factors influencing
changes in survival for a health insurance member, 2) we find evidence of
a significant association between serial measurements of cumulative private
insurance care usage and longevity, and 3) we obtain dynamic estimations of
event probabilities by exploiting the potential of joint models. In summary,
our contribution shows that an increase in health care usage intensity is
negatively associated with survival, but that its influence varies as usage
accumulates and depending on other factors such as sex and age, as well as
previous insurance conditions.
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2 Data and methods
The motivating dataset corresponds to the information provided by a Spanish
private health insurance mutual company, containing historical data which
started being collected on January 1st, 2006 and ended on February 1st,
2014. In particular, our study is limited to 39,399 insurance policy holders
(39.8% men and 60.2% women) who had reached the age of 65 before the
observation period started.
Table 2 presents the definition of the variables that are used in the anal-
ysis. Two variables are central in our study. First, the longitudinal process
which counts the number of times that the health insurance company has
provided a service to the policy holder. The unit service can be a variety
of possible coverage functions such as a doctor visit, a blood or an X-ray
test, a prescribed therapy, a hospital stay and any other treatment that is
established in the insurance contract. We do not distinguish between differ-
ent types of services at this stage, but obviously the accumulated number of
unit services provided over time to a given patient is strongly correlated with
her health condition. Due to the right skewed shape exhibited by the longi-
tudinal outcome, a logarithmic scale is applied (Verbeke and Molenberghs,
2009). Second, we also consider the survival time, where the event of interest
is death. Information is censored because the majority of individuals sur-
vive beyond the end of the study period. Some other cancel their insurance
policy and therefore they quit the study automatically. These dropouts are
considered random, as they are generally due to personal reasons such as the
decision not to renew the policy, or a change of company.
In one part of our study, variables such as gender, age and the cumulative
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Table 1: Variables in the private insurer data set (2006-2014)
Variable name Definition
ID Subject identifier: i = 1, 2, . . . , 30580
SEX Gender of the subject: 0 = Male, 1 = Female
OBSTIME Age (years) in excess of 65 at each time point
CUM0 Cumulative number of private health service usage units
over the four years previous to entering the sample
CUM Cumulative number of private health service usage units
at each observation time point
TIME Final observation time (years), which may correspond
to an event(death) or to a right-censored data.
CENS Censoring indicator: 0 = Right-censored, 1 = Event
A private health service usage unit is a visit to a GP or a specialist,
a hospital spell, a medical test and so on
number of medical care service units play the role of baseline covariates and
become part of a first survival analysis. In another part, a longitudinal
analysis is presented, where the cumulative number of medical visits observed
in annual periods for each subject characterizes insurance intensity of use
until death. Finally, both models are considered jointly, thus establishing an
association parameter between the longitudinal and the survival processes.
The application of joint modeling techniques allows to determine whether
a pronounced increase in the cumulative number of coverage usage units
also implies a simultaneous increased risk of death for the subject. The
simultaneity is a fundamental part of joint modeling. When the two processes
are endogenously determined, they cannot be modeled separately.
The added value of joint models has been empirically illustrated by Fieuws
et al. (2008) who noted that predictions of failure in a kidney transplant study
based on a joint model using all recorded biomarkers of kidney functioning
substantially outperformed the separate analyses per marker. In addition,
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in a similar context, Rizopoulos (2011) and Proust-Lima and Taylor (2009b)
showed that joint models can also be aimed to dynamically update predic-
tions of survival probabilities and help in discriminating between patients
who have a high risk of experiencing the event of interest (e.g. death) in
relatively short time interval, from patients whose risk is rather minimal.
Let yi(t) = log.CUMi(t) = log{1+CUMi(t)} be the response variable of
the i -th subject, i = 1, . . . , n, observed at time t, where n is the total number
of observed individuals in the sample. The outcome is linearly related to a
set of p explanatory covariates and q random effects. In our application the
first response that is modeled is the number of private health usage service
units after a logarithmic transformation.
In addition, letmi(t) denote the true underlying value of the longitudinal
outcome, and Mi(t) = {mi(s), 0 ≤ s ≤ t} the complete longitudinal history.
The joint modeling approach consists in defining: (i) a model for the marker
trajectory, usually a mixed model, (ii) a model for the time-to-event, usually
a proportional hazard model, and (iii) linking both models using a shared
latent structure (Rizopoulos, 2011).
2.1 Longitudinal submodel: Random intercept model
The main goal of linear mixed effects models is to account for the special
features of serial evaluations of outcomes over time, thus being able to es-
tablish a plausible model in order to describe the particular evolution of
each subject included in a longitudinal study. The particular features of
these models are that they work with unbalanced datasets (unequal number
of follow-up measurements between subjects and varying times between re-
peated measurements of each subject), and that they can explicitly take into
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account that measurements from the same patient may be more correlated
than measurements from different patients.
The model is specified as follows:


log.CUMi(t) =mi(t)+ εi(t) = β0 + bi0 + β1t+ εi(t)
β = (β0, β1)
T
bi0 ∼ N (0, σ
2
b0
)
εi(t) ∼ N (0, σ
2)
This model is straightforward. It just postulates that, besides individual
random effects, a linear time trend governs the rate of increase of the number
of accumulated service units provided to insurance policy holders. This seems
plausible as we also expect that the older the policy holder the larger the rate
at which the number of requested services increases.
2.2 Survival submodel: PH Cox Model
The celebrated proportional-hazards Cox model (Cox, 1972) allows to model
the conditional hazard rate of survival times given certain baseline covariates.
It relies on a fundamental assumption, the proportionality of the hazards,
implying that the factors investigated have a constant impact on the risk
over time. The model provides the conditional hazard function hi(t|wi) at
time t of a subject’s profile given by a set of p time-independent explanatory
covariates called baseline covariates.
we assume that T ∗, or TIME in our data set, is a non-negative continuous
random variable which represents the exact time until some specified event,
which is death in our case. The survival model is specified through the hazard
function as follows:
hi(t|wi) = h0(t)Ri(t) exp{γlog.CUM0i},
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where h0(t) is an unspecified and non-negative baseline hazard function,
representing the hazard function where wi = 0, ψ(wi) is a non-negative
function which contains the information about the set of explanatory time-
independent covariates that define the i−th subject’s profile.
This model is defined as a semiparametric because a parametric form is
assumed only for the covariate effect, ψ(wi). Among the possible parame-
terizations of function ψ, the most widely used is an exponential expression:
ψ(wi;γ) = exp(γ
Twi), where γ = (γ1, γ2, . . . , γp)
T is the parameter vector.
Survival analysis is generally defined as a set of methods for analyzing
data where the outcome variable is the time until the occurrence of a specific
event of interest, usually designed by E . This time is called survival time,
time-to event or, simply, event time.
Bearing the above into account, what makes survival data special is that
the responses correspond to time-durations and thus they are not measured
in the same way as other variables. In practice, this fact has two important
consequences, namely that the distribution of survival times is often highly
left-skewed, and that the only information available about some subjects is
that they have not yet experienced the event E at the last time point of
follow-up, so these are termed censored or incomplete observations. In other
words, it is unknown when these remaining subjects will experience the event.
Considering these two special features, standard statistical methods can not
be applied to survival data.
Although there are various categories of censoring, the present work has
only focused on right-censoring mechanism which occurs when the subject
has not yet experienced the event of interest at the time when the follow-up
period ends. Consequently, all that is known about the true survival time is
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that it exceeds the observed survival time, t, at the study end. Furthermore,
we also assume that the censoring is non-informative. In this regard, it will
be assumed that there are only two reasons why right-censoring might occur:
The event of interest has not occurred by the end of the follow-up period
(study end) or a subject is discontinued of follow-up during the study period
due to causes unrelated to the event of interest.
The Cox model is often called a proportional hazards (PH) model be-
cause, two individuals i and i′ with respective covariate values wi and wi′ ,
have a constant hazard rate ratio, so their corresponding hazard rates are
proportional to each other and do not depend on time.
2.3 Joint model for longitudinal and survival data
To account for the fact that the longitudinal marker is an endogenous time-
dependent covariate measured with error (Kalbfleisch and Prentice, 2002)
with respect to survival, it is assumed that the risk for an event depends on
the true and unobserved value of the endogenous variable at time t, denoted
by mi(t). The endogeneity probles is quite intuitive here. There is a latent
factor causing a health deterioration, which in turn implies an increase in the
risk of death and more intensity of health care service use. So, survival and
health care are strongly related to one another, through this latent factor.
The true underlying value of the longitudinal outcome, mi(t) must be
estimated in order to successfully reconstruct the complete longitudinal his-
tory Mi(t). For this purpose, we utilize all available measurements on each
subject {yi(tij), for i = 1, . . . , n and j = 1, . . . , ni} and postulate a suitable
mixed effects model. We focus on normal data, describing the true subject-
specific evolutions by a linear mixed effects model, but we agree that a count
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data modeling approach would probably bee more suitable.
In order to quantify the effect of the true outcomemi(t) on the risk for the
event at specific time t, we use a relative risk model of the form (Therneau
and Grambsch, 2000).
hi(t|Mi(t),wi) = h0(t) exp{γ
Twi + αmi(t)}, t > 0, (1)
whereMi(t) = {mi(s), 0 ≤ s ≤ t} denotes the history of the true unobserved
longitudinal process for subject i up to time point t. The parameter α quan-
tifies the degree of association between the longitudinal marker and the risk
for the event.
In standard survival analysis, the baseline risk function h0(·) is typically
left completely unspecified (Cox, 1972; Andersen and Gill, 1982). However,
within the joint modeling framework (Hsieh et al., 2006) noted that leav-
ing this function completely unspecified leads to an underestimation of the
standard errors of the parameter estimates, so it is necessary to explicitly
define h0(·). Although we could have used the hazard function of a standard
survival distribution (e.g. Weibull or Gamma), we finally opted for a more
flexible solution such a piecewise-constant model:
h0(t) =
Q∑
q=1
ξqI(νq−1 < t ≤ νq), (2)
where 0 = ν0 < ν1 < . . . < νQ denotes a split of the time scale, with νQ
being the largest observed time, and ξq denotes the value of the hazard in
the interval (νq−1, νq].
On the basis of the expressed considerations, the true and unobserved
outcome at a specific time point t can be modeled by joining the two above
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approaches (Rizopoulos, 2012)
hi(t|Mi(t),wi) = h0(t)Ri(t) exp{γlog.CUM0i + α(β0 + bi0 + β1t)}. (3)
In particular, the hazard at age t for the i−th individual, with a true
longitudinal profile Mi(t) up to time t, can be expressed as follows:
hi(t|Mi(t),wi) = h0(t)Ri(t) exp
[
γTwi + α{x
T
i (t)β + z
T
i (t)bi}
]
. (4)
The models presented in this section can be generalized to higher di-
mensions (Andrinopoulou et al., 2014). More information on joint modeling
fitting can be found in Rizopoulos (2012) and details about the R package
implementation are given in Rizopoulos (2010).
2.4 Predicted survival in joint models
Once the model has been specified, estimated and validated, a powerful fea-
ture is to derive survival predictions. Thus, considering the sample Dn =
{Ti, δi,yi; i = 1, . . . , n} on which the joint model was fitted, the goal consists
of predicting conditional probability of surviving time for a new subject i that
provides a set of longitudinal measurements, Yi(t) = {yi(s); 0 ≤ s < t} and
a vector of baseline covariates, wi. The flexibility provided by the joint mod-
eling approach is in line with a growing trend towards personalized medicine
(Garre et al., 2008; Proust-Lima and Taylor, 2009a; Rizopoulos, 2011). In
particular, the real challenge focuses on estimating these probabilities not
only at each one of the time points measurements, but also at a generic time
u > t given survival up to t, i.e.
pii(u|t) = Pr(T
∗
i ≥ u | T
∗
i > t,Yi(t),wi,Dn;θ
∗), (5)
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where θ∗ denotes the true parameter values.
This approach therefore allows to obtain the so called survival dynamic
predictions for the i−th subject, arising from his survival curve which is up-
dated on the basis of any new longitudinal information that is subsequently
collected. Hence, as new information at time t′ > t is added to existing longi-
tudinal measurements, one can update the estimated survival curve pii(u | t)
to pii(u | t
′), and therefore proceed in a time dynamic manner.
The estimation of the subject-specific conditional survival probabilities
takes full advantage of the conditional independence used to define the joint
model. Using a Bayesian formulation (Proust-Lima and Taylor, 2009a; Ri-
zopoulos, 2011), the problem can be written as:
Pr(T ∗i ≥ u | T
∗
i > t,Yi(t),Dn)
=
∫
θ
Pr(T ∗i ≥ u | T
∗
i > t,Yi(t);θ)p(θ | Dn)dθ.
(6)
The first part of the above integrand is given by
Pr(T ∗i ≥ u | T
∗
i > t,Yi(t);θ)
=
∫
bi
Si{u | Mi(u,bi,θ);θ}
Si{t | Mi(t,bi,θ);θ}
p(bi | T
∗
i > t,Yi(t);θ)dbi,
(7)
where Si(·) denotes the survival function, and furthermore it has been ex-
plicitly noted that the true longitudinal history Mi(·) is a function of both
the random effects and the parameters. For the second part of equation (6),
it is assumed that the sample size n is large enough, such that {θ;Dn} can
be well approximated by N{θˆ, V̂ar(θˆ)}.
By combining (6), (7) and {θ;Dn} ∼ N{θˆ, V̂ar(θˆ)}, a Monte Carlo esti-
mate of pii(u | t) can be derived using the following simulation scheme:
• Draw a value of θ(l) from a normal distribution N{θˆ, V̂ar(θˆ)}
• Draw a value of b(l)i from the pool.
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• Compute pi(l)i (u | t) as
Si{u | Mi(u,b
(l)
i ,θ
(l));θ(l)}/Si{t | Mi(t,b
(l)
i ,θ
(l));θ(l)}. (8)
The three steeps are repeated l = 1, . . . , L times, where L denotes the
number of Monte Carlo samples. The realizations {pi(l)i (u | t) , l = 1, . . . , L}
can be used to derive point estimates of pii(u | t), such as the median and
the mean values as follows:
pii
(l)(u | t) = median{pi(l)i (u | t) , l = 1, . . . , L} (9)
pii
(l)(u | t) =
1
L
L∑
l=1
pi
(l)
i (u | t). (10)
From these estimates, it is also possible to compute the standard errors
using the sample standard deviation over the Monte Carlo samples and the
confidence intervals through the sample percentiles.
3 Results and predictions
The results for the private mutual insurer data set are presented in Table 3
separately for men and women. The association parameter α is positive and
significantly different from zero. This indicates that the larger the number
of accumulated service units provided the larger the risk of death. This is
consistent with intuition as an aggravated patient has a higher probability
of death and as a consequence, he demands health care resources. At the
same time, who demand health care services are certainly motivated by a
deteriorated health condition and therefore expected survival time decreases.
Note that a positive parameter factor in the hazard function means that the
risk of death increases, whereas a negative parameter has the contrary effect.
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Table 2: Results of the joint model estimation in the private insurer data set
(2006-2014)
Men Women
Parameters Estimate 95% CI Estimate 95% CI
β0 2.140
∗ (2.100, 2.180) 2.158∗ (2.123, 2.192)
β1 0.170
∗ (0.167, 0.172) 0.157∗ (0.155, 0.159)
σ 0.332∗ (0.329, 0.334) 0.314∗ (0.312, 0.316)
σb0 1.648
∗ (1.597, 1.698) 1.791∗ (1.748, 1.834)
γ -1.174∗ (-1.306,-1.042) -0.964 (-1.042, -0.887)
α 1.437∗ (1.275, 1.598) 1.273∗ (1.179, 1.367)
∗ indicates significance at the 5% level. CI stands for confidence
interval.
We note that the association between the longitudinal process and the sur-
vival outcome is slightly higher for men (1.437) than for women (1.273), but
the difference is not statistically significant. All other parameter estimates
are similar for mean and women except for γ, which is not significantly dif-
ferent from zero for women. This means that pre-existing conditions, which
are represented by log.CUM0 and which refer to the number of accumulated
services receive during the four years previous to the study, do not influence
the survival of women, while they do influence negatively the hazard rate
for men. This result seems to indicate that a larger survival is expected for
those who were using medical care more intensively than others. This result
also means that if a patient accumulates a large number of services, but was
able to survive to the starting date of the study, then he has a smaller hazard
rate of death compared to another subject who has not accumulated as many
services as him. This can be interpreted as the preventive effect or health
care or the curative effect, which prove to be efficiently leading to longer life
expectancy.
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However, if suddenly a patient requires medical care, the number of accu-
mulated services increases and therefore, since parameters β0, β1 and α are
positive, that would synchronize with the hazard rate, which would increase
and lead to a higher risk of death.
A log-unit increase in the cumulate number of visits entails a exp(1.437) =
4.2-fold increase in the men risk and exp(1.273) = 3.6-fold increase for
women.
Some comments on σ and σb0 are needed. Those two parameters can be
interpreted as an inherent variability in the random effects of the longitudinal
model. Note that σb0 is slightly larger for women than for men, which could
also be caused by the fact that the average age is larger for women than for
men in this particular sample.
As an illustration, let us consider for instance the case of a woman 65
aged at study start point, for whom her cumulate service received during the
four years prior to the study starting time point is known. In Figure 3 we
can observe how the model updates the predicted survival probabilities as
new longitudinal information is collected. This is a very useful prognostic
tool.
4 Conclusions
From the analysis of our private insurance longitudinal data sample, we con-
clude that the observed number of cumulated health care service units pro-
vided is strongly as positively associated with the risk of death.
The baseline cumulated number of cumulated health care service units
provided to a patient has a protective effect. This is in line with evidence of
15
Figure 1: Dynamic survival probabilities for a woman aged 65 who is still
alive at the end of the study
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a preventive affect.
The joint modeling methodology allows to continuously update the pre-
dictions of subject-specific survival probabilities, when new information on
service usage comes along.
Further work is going to be pursued on the generalization of the statis-
tical model to counting processes and to the implementation of multivariate
longitudinal markers, as they seem very natural here. Indeed the number of
medical care services needed can be categorized in big groups, those that are
routine programmed actions and exceptional treatments, such as surgery or
serious procedures.
One of the limitations of our study is the fact that all health services have
the same importance in the longitudinal counter. Another practical issues is
the fact that insurance customers switch between companies and new policy
holders could enter the sample or leave the group motivated by health-related
problems. We do not think that this was a problem in this particular data
set. Since our policyholder were above 65 years of age, they have been in
this mutual company for several year , because it is very infrequent to change
16
the health insurance provider at this age. we do not expect to have adverse
selection in this group of policy holders.
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